Hepatitis virus B e antigen subtypes HBeAg/1 and HBeAg/2 can be distinguished by a micro-Ouchterlony immunodiffusion assay and a solid-phase radioimmunoassay using serum IgG-associated HBeAgs and liver-and serum-derived IgG-free HBeAgs. The liver-and serum-derived HBeAg consisted of two different antigenicities, HBeAg/I and HBeAg/2. Both the liver-derived HBeAg/I and HBeAg/2 had mol. wt. of 30 000 (monomer) and 90 000 (trimer) and shared the same isoelectric point of 4-3 to 4.8. Approximately 80~ of liver-derived HBeAg (mol. wt. 30 000 and 90 000) had HBeAg/1 activity and the remaining 20~ was HBeAg/2. The serum-derived HBeAg/1 and HBeAg/2 were both associated with IgG to form heterogeneous moieties with apparent mol. wt. of 240000, 400000 and 540000 or were free, with mol. wt. 30000 (monomer) and 90 000 (trimer). The serum HBeAg of mol. wt. 90 000 was further differentiated into two molecular species, one trimer and the other associated with albumin. Large types of both HBeAg/1 and HBeAg/2 were recovered by isoelectrictric focusing at pH 5-5 to 7-5 (mol. wt. 240000), 5-7 to 8-0 (mol. wt. 400000) and 6.4 to 8-4 (mol. wt. 540000) respectively, while small types of both exhibited a narrower range of isoelectric points similar to liver-derived antigens. In most sera, antigenicity of half of the serum IgGassociated HBeAg was HBeAg/1 and the remaining 50~ was HBeAg/2, whereas 80~ of the free HBeAg had HBeAg/1 activity and the remaining 20 ~ was HBeAg/2. These results indicate that HBeAg/1 and HBeAg/2, although antigenically distinct, are very similar physicochemically with respect to both mol. wt. and isoelectric point.
INTRODUCTION
A third antigen (HBeAg) associated with infection by hepatitis B virus (HBV) is distinct from the hepatitis B surface antigen (HBsAg) and the core antigen (HBcAg) (Magnius & Espmark, 1972) . Those HBsAg-positive sera containing HBeAg are known to contain a large number of Dane particles and to have high DNA polymerase activity (Nordenfelt & Kjellen, 1975; Maynard et al., 1976) .
The close physical correlation between HBeAg and Dane particles was examined earlier (Ohori et al., , 1980 Takahashi et al., 1979; Yoshizawa et al., 1979) , and HBeAg is now Yamada et al., 1979 Yamada et al., , 1981 . In earlier reports from our laboratory (Yamada et al., 1979 (Yamada et al., , 1981 , it was demonstrated that free 'small' mol. wt. HBeAgs consisted of two different molecules; one with a mol. wt. of 30 000 (monomer), and the other of 90 000 (trimer). 'Large' mol. wt. H BeAgs (240000, 400000 and 540 000) were associated with IgG in ratios of one molecule of HBeAg to one, two and three molecules of IgG respectively. On the other hand, the liver-derived HBeAgs consisted almost exclusively of the 30000 and 90000 mol. wt. species.
Up to the present, the diversity of the HBeAg system has been well documented only by immunodiffusion. There appear to be at least two We have developed a solid-phase radioimmunoassay (RIA) for discrimination between HBeAg/1 and HBeAg/2 subspecificities. The present work was undertaken to analyse immunochemical subspecificities of HBeAg in the liver and serum and to define their relationship with subtype components of HBeAg, and in addition to demonstrate the existence of anti-HBeAg active IgG molecules bound to small peptide moieties of HBeAg.
METHODS

Serological testing.
HBeAg was detected and titrated by immunodiffusion in agarose gel (Magnius & Espmark, 1972) . HBeAg and anti-HBeAg materials were acquired from HBeAg-positive donors as reported previously (Yamada et al., 1979) . The standard HBeAg reagents contained the Williams' el and e 2 antigen reactivities (Williams & Le Bouvier, 1976) . Agarose plates were made from 0.8 ~ agarose (Agarose A-37; Nakarai Chemicals Ltd., Kyoto, Japan), dissolved in Tris-NaC1 buffer pH 7-5, containing 0.1 M-Tris-HCl, 0-1 M-NaC1, 0-01 M-EDTA, 2 ~ polyethylene glycol 6000 (average mol. wt. 7500, Wako Pure Chemicals, Osaka, Japan), and 0-01 sodium azide. In the micro-Ouchterlony immunodiffusion assay (MO), the reciprocal of the highest dilution that gave a precipitin band against standard serum was taken as the HBeAg titre.
The titres of HBeAg and HBcAg were determined by the reverse passive haemagglutination (R-PHA) method (Yamada et al., 1979; Ohori et al., 1980) . Radioimmunoassay (RIA)for HBeAg and anti-HBeAg. HBeAg was determined by using a solid-phase radioimmunoassay HBe RIA Kit (Master Lot No. 12-545-HR; Abbott Laboratories, North Chicago, IlL, U.S.A.) . HBeAg in the test samples was assayed semi-quantitatively by the RIA method. Two sets of serial twofold dilutions of the test samples were prepared in phosphate buffer (0.1 M, pH 7.6) supplemented with 0.1 M-NaC1 (PBS) in an acrylic plate. One set was combined with 100 p.1 PBS, and the other set with 100 ~tl PBS containing anti-HBeAg (RIA titre, 1:25600) as a control. After incubating the plate at 37 °C for 2 h, a polystyrene bead coated with anti-HBeAg was added to each well, and the plate was further incubated at room temperature for 24 h. After washing with distilled water (15 ml), the bead was further incubated in 200 ~tl t25I-labelled anti-HBeAg solution at 45 °C for 4 h. The bead was then washed with distilled water (15 ml) and the radioactivity counted .
Anti-HBeAg was determined by a neutralization procedure: 100 ktl of test sample was mixed with 100 Ixl of diluted HBeAg-positive reagent containing a predetermined quantity of HBeAg and allowed to stand at 37 °C for 2 h; an antibody-coated bead was added and the incubation continued for 24 h. After washing, the bead was incubated with ~ 2SI-labelled anti-HBeAg (200 ~tl) at 45 °C for 4 h. The bead was then washed with distilled water (15 ml) and counted for radioactivity. Significant (50 ~o) reduction of count rate indicated the presence of antiHBeAg in the test sample.
Preparation oflgG-associated and IgG-free HBeAgsfrom sera. The sera of asymptomatic carriers of HBsAgs with high HBeAg titres were selected, pooled and used for the purification of serum-derived HBeAg. Principally, the purification was carried out by a combination of salting-out precipitation, ion-exchange chromatography, affinity chromatography, gel filtration and isoelectric focusing as described previously (Yamada et al., 1981) . The serum pool was spun down by centrifugation at 124000 g for 3 h in a Hitachi RP-42 rotor and the supernatant was used as the starting material.
For the preparation of IgG-associated HBeAg, the precipitate obtained with 1-33 ~I-(NH4)2SO4 was dissolved in Tris-NaCl buffer and subjected to ion-exchange chromatography on DEAE-Sepharose CL-6B with 0-01 Mcitrate pH 5.8, gel filtration on AcA34 and finally isoelectric focusing. Fractions with HBeAg activity were pooled and served as the IgG-associated HBeAg preparation (Yamada et al., 1981 For the preparation of IgG-free HBeAg, the superuatant obtained from 1-33 M-(NH4)2SO4 was made 3.24 M with (NH4)2SO~ and centrifuged. The precipitate was solubilized in Tris-NaC1 buffer and subjected to ionexchange chromatography on DEAE-Sepharose CL-6B (0-04 M-citrate pH 5.8), affinity chromatography with anti-human IgG, gel filtration on AcA34 and finally subjected to isoelectric focusing. Fractions with HBeAg activity were pooled and served as the IgG-free HBeAg preparation (Yamada et al., 1981) .
Preparation of liver-derived HSeAg. Liver-derived HBeAg was prepared by a combination of gel filtration and isoelectric focusing (Yamada et al., 1981) . The starting material was obtained from a 5 g liver sample from autopsy of a patient with subacute hepatitis. The tissue was minced into small fragments, homogenized in a Sorvall Omnimixer with 6 vol. chilled Tris-NaCl buffer and centrifuged at 1,23400 g for 20 h in a Hitachi RP50-2 rotor. Dane and core particles were completely pelleted. The resulting supernatant was also subjected to gel filtration with AcA34 and isoelectric focusing (Yamada et al., 1981) .
Preparation of human anti-HBeAg IgG. Ten ml of anti-HBeAg-containing plasma was converted to serum. The IgG fraction was purified by precipitation with an equal volume of 4 M-(NH4)2SO4 followed by chromatography on DEAE-cellulose in 0-01 M-phosphate buffer pH 8.
Separation of lgG from IgG-associated HBeAg. IgG-associated HBeAg, obtained by successive purification (0.01 M-citrate eluate of DEAE-Sepharose CL-6B column, DEAE-cellulose chromatography, gel filtration and isoelectric focusing), was applied to an affinity column (2 x 10 cm) of human anti-HBeAg IgG-conjugated Sepharose 4B (Takahashi et al., 1978) . The column was washed with 1000 ml Tris-NaC1 buffer and then bound
HBeAg was eluted by 3 M-ammonium thiocyanate. The eluate was extensively dialysed against Tris-NaC1 buffer containing 6 M-guanidine-HC1. This sample was then applied to a Sepharose 6B column (1.5 × 80 cm) which had been equilibrated with Tris-NaCl pH 7-5, containing 6 M-guanidine-HC1.
RESULTS
Discrimination of HBeAg/1 and HBeAg/2 by immunodiffusion
The MO method was used to discriminate between the antigenicities of HBeAg/1 and HBeAg/2. The IgG-associated 'large' HBeAg which was obtained from the 1.33 M-(~NH4)2SO4 precipitate followed by chromatography on DEAE-Sepharose with 0-01 M-citrate contained HBeAg/1 (MO titre 1:2 s) and HBeAg/2 (MO titre 1:25). To this preparation, IgG of antiHBeAg/1 (MO titre 1:26) was added and incubated for 24h at 4 °C. The precipitate was collected by centrifugation at 10000 g for 30 rain at 4 °C and discarded. The supernatant was used as the IgG-associated 'large' HBeAg/2 (MO titre I :2s). The free 'small' HBeAg which was obtained from 1.33 to 3.24 M-(NH4)2SO4 followed by chromatography on DEAE-Sepharose with 0.04 M-citrate elution contained HBeAg/I (MO titre 1 : 25) and HBeAg/2 (MO titre 1:23). Anti-HBeAg/2 IgG (MO titre 1 : 24) was added to this fraction and incubated for 24 h at 4 °C. The precipitate was separated by centrifugation at 10000 g for 30 min at 4 °C and discarded. The supernatant of this fraction was used as the free 'small' HBeAg/1 (MO titre 1:25). Fig. I shows the immunodiffusion profiles of HBeAg/1 and HBeAg/2. The antigen in well A is a reconstructed mixture of free 'small' HBeAg/I (MO titre 1:2 s) and IgG-associated 'large' HBeAg/2 (MO titre 1:25). The centre well B contained standard antibody that had antiHBeAg/1 and anti-HBeAg/2 activities. The free 'small' HBeAg/I precipitin band was formed closer to the antibody well, while that of the IgG-associated 'large' HBeAg/2 was closer to the antigen well. When the standard IgG fraction containing anti-HBeAg/2 (MO titre 1:26) was added to the reconstructed mixture of free 'small' HBeAg/1 (MO titre 1:25) and IgG-associated 'large' HBeAg/2 (MO titre 1:25), only the precipitin band of HBeAg/1 remained (MO titre 1:2 s) (Fig. 1, well C) .
Discrimination of HBeAg/1 and HBeAg/2 by RIA
For the determination of HBeAg titre, the standard antigen preparation containing both HBeAg/1 and HBeAg/2 was serially diluted as described in Methods and assayed for HBeAg. The HBeAg/1 and HBeAg/2 each had an MO titre of 1:25 and the total HBeAg activity had an RIA titre of 1:25600. Fig. 2 shows the titration curves for HBeAg/1 and HBeAg/2. The IgG fraction containing anti-HBeAg/2 (MO titre 1:26) was added to the standard antigen preparation containing both HBeAg/1 (MO titre 1:25) and HBeAg/2 (MO titre 1:25) and incubated for 24 h at 4 °C. The precipitate was separated by centrifugation at 10000 g for 30 min at 4 °C and discarded. The supernatant of this fraction was diluted in a twofold series. A HBeAgs were serially diluted in twofold increments, and each dilution was analysed for HBeAg by direct immunoassay. The HBeAg/1 and HBeAg/2 each had an MO titre of 1 : 2 s and the total HBeAg activity had an RIA titre of 1:25600 (O). When the IgG fraction containing anti-HBeAg/2 (MO titre 1 : 26 ; RIA titre 1 : 25600) was added to the standard antigens containing both HBeAg/1 (MO titre 1 : 2 s) and HBeAg/2 (MO titre 1:25), only HBeAg/1 activity remained (MO titre 1:25; RIA titre 1:12800 (A). When the IgG fraction containing anti-HBeAg/1 (MO titre 1:26 ; RIA titre 1:25 600) was further added to this system, HBeAg/1 activity was reduced to a level undetectable by the MO and RIA methods. On the other hand, when the IgG of anti-HBeAg/1 (MO titre 1 : 26 ; RIA titre 1 : 25 600) was added to the standard antigens, only HBeAg/2 activity remained (MO titre 1:25 ; RIA titre 1:12800) (I). Similarly, when the IgG ofanti-HBeAg/2 (MO titre 1 : 26 ; RIA titre 1:25 600) was further added to this system, HBeA~/2 activity was reduced to a level undetectable by the assay methods. The negative control had 401 ct/min and the horizontal dashed line indicates a level 2.1 times that of this value.
polystyrene bead coated with anti-HBeAg was added to each well, and counted for 125I-1abelled anti-HBeAg uptake, as described in Methods. As shown in Fig. 2 , the titre of HBeAg was estimated to be 1 : 12 800. The HBeAg titre was reduced to one-half of total HBeAg activity of the original sample, indicating that this HBeAg titre reflected the titre of HBeAg/1. These results were confirmed by MO. When the standard IgG fraction containing anti-HBeAg/2 (MO titre 1:26) was added to the standard antigen preparation containing both HBeAg/1 (MO titre 1:25) and HBeAg/2 (MO titre 1:25), only HBeAg/1 activity remained (MO titre l :2s). W h e n the IgG of anti-HBeAg/1 (MO titre 1:26) was added to this system, HBeAg/1 activity was reduced to an undetectable level by the MO and R I A methods. Therefore, it can be calculated that the titre of the HBeAg/1 activity was 12800 (i.e. 25600 to 12800) and the same for HBeAg/2. 
HBeAg/ I and HBeAg/2 from serum and liver have the same molecular weight
IgG-associated 'large' HBeAg and free 'small' HBeAg which had been purified from sera of asymptomatic carriers of HBV (Yamada et al., 1981) were assayed for both HBeAg/1 and HBeAg/2 by MO and RIA. Fig. 3 shows immunodiffusion of IgG-associated 'large' and free 'small' HBeAg obtained from gel filtration in the AcA34 column. Three peaks of HBeAgs associated with IgG of tool. wt. 240000, 400000 and 540000 were obtained, as described previously (Yamada et al., 1981) . Measurement of HBeAg/1 and HBeAg/2 in these molecular size ranges was by MO and RIA and it was found that approximately half was HBeAg/1 (MO titre 1 : 25 ; RIA titre 1 : 12800) and the remaining 50% was HBeAg/2 (MO titre 1:25; RIA titre 1:12800).
Two peaks of IgG-free HBeAg of mol. wt. 30000 and 90000 were obtained as described previously (Yamada et al., 1981) . The same analysis was conducted on these IgG-free HBeAgs. Approximately 80% of the serum IgG-free HBeAg (both molecular weights, 90000 and 30000) had HBeAg/I activity (MO titre 1 ;23 , RIA titre 1 : 3200) and the remaining 20% had HBeAg/2 activity (MO titre 1 : 21 ; RIA titre 1 : 800).
Only half of the serum HBeAg of mol. wt. 90 000 adsorbed to an affinity column of anti-human serum albumin, suggesting that at least a part of this HBeAg was associated with serum albumin, as previously described (Yamada et al., 1981) . About 80% of the albumin-associated HBeAg (tool. wt. 90000) as HBeAg/1 (MO titre 1:23 ; RIA titre 1 : 3200) and the remaining 20% was HBeAg/2 (MO titre 1:21; RIA titre 1:800) (data not shown).
Similarly, approximately 80% of the liver-derived HBeAg (both 90000 and 30000 tool. wt.) was HBeAg/1 (MO titre 1:23 ; RIA titre 1:3200) and the remaining 20% was HBeAg/2 (MO titre 1 : 21 ; RIA titre 1 : 800). The results obtained from the above experiments are summarized in Table 1 . 
HBeAg/1 and HBeAg/2 from serum and liver have the same isoelectric point
In a more detailed analysis of IgG-associated HBeAg (mol. wt. 240000, 400000 and 540000), fractions from gel filtration were subjected to isoelectric focusing. Both HBeAg/1 and HBeAg/2 were recovered at pH 6-4 to 8-4 (Fig. 4a, tool. wt. 540000), 5.7 to 8.0 (Fig. 4b, tool. wt. 400000) and 5.5 to 7.5 (Fig. 4c, tool. wt. 240000). In a similar analysis, both HBeAg/1 and HBeAg/2 obtained from the albumin-associated serum HBeAg were recovered at pH 4.4 to 5.1 (Fig. 5 a) . A similar, but slightly narrower, isoelectric point range of 4.3 to 4.8 was obtained when the two free HBeAg/1 and HBeAg/2 (both the 90000 and 30000 tool. wt. species) from liver were examined (Fig. 5b, c) . Fig. 4 and 5 show the MO titres of HBeAg/1 and HBeAg/2 of IgG-associated and IgG-free HBeAgs respectively, all of which were separated by a combination of gel filtration and isoelectric focusing. Again, the ratios of HBeAg/1 to HBeAg/2 of IgG-associated HBeAg and IgG-free HBeAg were 1:1 (Fig. 4) and 4:1 (Fig. 5) respectively.
The results show that monomers (tool. wt. 30000) and trimers (tool. wt. 90000) obtained from serum and liver have a similar pI and both HBeAg/1 and HBeAg/2 associated with IgG have a higher pI, as described previously (Yamada et al., 1981) . Also, the ratios of HBeAg/1 to HBeAg/2 in free 'small' HBeAg differed irrespective of their origin from liver or serum. On the other hand, the same ratio of HBeAg/1 to HBeAg/2 was found in 'large' HBeAg which was derived from serum.
Immunological properties of IgG bound to HBeAgs
In a previous report (Yamada et al., 1981) , we demonstrated that the IgG from IgG-associated HBeAg was specifically anti-HBeAg. However, our evidence was inconclusive because the complexes were not completely dissociated by 5 M-urea. In a more detailed analysis of these complexes, purified IgG-associated HBeAg obtained after ion-exchange chromatography, gel filtration, isoelectric focusing and finally anti-HBeAg affinity chromatography was dialysed against Tris-NaC1 buffer containing 6 M-guanidine-HCl, and were chromatographed on Sepharose 6B. The free IgG fraction that was eluted at the position of mol. wt. 160000 was found to have both anti-HBeAg/1 activity (RIA titre 1 : 128) and anti-HBeAg/2 activity (RIA titre 1:128) by radioimmunoassay (Fig. 6) .
E. YAMADA AND OTHERS
The protein unit of HBeAg
As shown in Fig. 6 , the smaller molecular weight fractions (32000 and 16000 in the ratio of 2:1) exhibited both HBeAg/1 (RIA titre 1:128 and 1:64) and HBeAg/2 (RIA titre 1:128 and 1:64) activities. When free HBeAgs (both 90000 and 30000 mol. wt.) from the liver or serum were chromatographed in the same way, they resolved into the same mol. wt. fractions (32000 and 16000) which had both HBeAg/1 and HBeAg/2 activities (data not shown).
Furthermore, when the 32000 mol. wt. component of HBeAg/1 and HBeAg/2 was subjected to gel filtration in 6 M-guanidine-HC1, species of mol. wt. 32000 and 16000 in the ratio of 2 : 1 were obtained. However, when the 32000 mol. wt. protein was heated at 100 °C for 2 min in the presence of 6 ra-guanidine-HC1, all the HBeAg/1 and H BeAg/2 activities migrated to the 16000 mol. wt. position (data not shown). These results indicate that HBeAgs having a mol. wt. of 32000 most likely represent dimers of 16000 dalton component.
DISCUSSION
Immunodiffusion analysis has shown that HBeAg is antigenically distinct from HBsAg and HBcAg. However, the low sensitivity of immunodiffusion techniques for detection of HBeAg and anti-HBeAg suggested the need for a more sensitive method. The use of RIA has revealed that the appearance of HBeAg is a usual consequence of hepatitis B virus infection and demonstrated a seroconversion of HBeAg to anti-HBeAg in acute hepatitis B virus infection (Fr6sner et al., 1978) . RIA should be useful for a better analysis of subspecificities of HBeAg, such as HBeAg/1 and HBeAg/2, and to examine the association between HBeAg and core particles.
We have attempted to discriminate between HBeAg/1 and HBeAg/2 by the MO and RIA methods by utilizing the difference in seroreactivity between HBeAg/1 and HBeAg/2. When the IgG fraction containing anti-HBeAg/2 was added to the sample containing both HBeAg/1 and HBeAg/2, only HBeAg/1 remained. Furthermore, when the IgG of anti-HBeAg/1 was added to this system, HBeAg/1 activity was reduced to undetectable levels as measured by MO and RIA. These results suggest that HBeAg/1 and HBeAg/2 are serologically different from each other. Le Bouvier (1976) and Miller et al. (1978) reported that HBeAg-positive sera were relatively rich in HBeAg/1, whereas the antibody was predominantly anti-HBeAg/2. Moreover, HBeAg/1 was invariably found whenever HBeAg was detected, whereas HBeAg/2 levels fluctuated widely in individual patients over time. Fields et al. (1978) reported that chimpanzee anti-HBeAg/2 was developed by repeated immunizations with purified antigen containing HBeAg/1 and HBeAg/2. However, anti-HBeAg/1 was not detected despite the presence of HBeAg/1 in the inoculum. Trepo et al. (1980) found that anti-HBeAg/2 [anti-HBeAg/1 in the nomenclature of Trepo et al. (1978) ] was the first antibody detected and anti-HBeAg/1 [antiHBeAg/3, Trepo et al. (1978) ] appeared less frequently. In our work (Ohori et al., 1980) , we detected HBeAg/2 less frequently than HBeAg/1 in HBsAg-positive sera and usually all sera having HBeAg/2 were positive for HBeAg/1. The initial detection of HBeAg/2 occurred at or just before the elevation of the liver transaminase level; on the other hand, HBeAg/1 was detected relatively early after transfusion of HBsAg-positive blood. Moreover, HBeAg/1 persisted longer.
Taking into consideration the results of epidemiological studies (Fields et al., 1978; Ohori et al., 1980) as well as our results presented in Fig. 4 and 5, the different ratios of HBeAg/1 to HBeAg/2 in 'small' and 'large' HBeAgs can be summarized as follows. (i) Usually, HBeAg/1 is synthesized in larger amounts than HBeAg/2 in infected liver. (ii) The different ratio of HBeAg/1 to HBeAg/2 in liver is reflected in serum even after HBsAg is excreted into the bloodstream. (iii) If one assumes that anti-HBeAg/1 and anti-HBeAg/2 are produced simultaneously during type B hepatitis infection, both HBeAg/1 and HBeAg/2 can bind antibody. However, because large amounts of only HBeAg/1 are released from liver continuously, only HBeAg/1 will remain in the free form.
Although HBeAg/1 and HBeAg/2 both migrated as 16000 mol. wt. species after heating at 100 °C in the presence of 6 M-guanidine-HC1, indicating that the 32000 tool. wt. activities of HBeAg/1 and HBeAg/2 most likely represent dimers, we do not know whether the polypeptides of HBeAg/1 and HBeAg/2 are identical. Recently, we have identified a major polypeptide of tool. wt. 16000 and minor polypeptides of 21000 and 14000 mol. wt. from HBeAg/1 and HBeAg/2 in serum fractions. Furthermore, we consider the 16000 and 14000 tool. wt. polypeptides to be the degraded products of the 21000 tool. wt. polypeptide (data not shown). Budkowska et al. (1979) found that, although HBeAg/1 and HBeAg/2 were absent from the surface of core particles, they could be exposed by treating with SDS and 2-mercaptoethanol.
We have confirmed this observation (H. Ohori et al., unpublished results) .
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